Search for other papers by Emilio Fiore in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
inducing thyroid autoimmunity is also strongly supported by animal models. Excessive iodine intake can precipitate spontaneous thyroiditis in genetically predisposed animals by increasing the immunogenicity of thyroglobulin (Tg) [ 21 ]. This may be
Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Search for other papers by Maria Prado Talavera Rubio in
Google Scholar
PubMed
Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
patient based on the response to initial therapy (excellent, indeterminate, biochemical incomplete and structural incomplete response) using Preablation thyroglobulin (pTg), preablation AntiTg antibodies (pAntiTgAb), ultrasonography (US), diagnostic whole
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
evidence of disease presence. Although the 18 F-fludeoxyglucose (FDG) PET/CT scan has a well-established role in detecting disease in RRD [ 1 ], the relation of the rate of thyroglobulin (Tg) rise or stimulated Tg level with the likelihood of disease
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Search for other papers by Patricia Bretones in
Google Scholar
PubMed
Search for other papers by Juliette Abeillon in
Google Scholar
PubMed
Search for other papers by Myriam Moret in
Google Scholar
PubMed
Search for other papers by Pauline Perrin in
Google Scholar
PubMed
Search for other papers by Karim Chikh in
Google Scholar
PubMed
Search for other papers by Véronique Raverot in
Google Scholar
PubMed
the reference range (<1.75 IU/L). Anti-thyroglobulin antibodies were less than 25 IU/mL (reference range <115) and thyroglobulin level was 9.4 µg/L (reference range 3.5–77). The thyroid gland was eutopic with a normal size on cervical ultrasonography
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Introduction Current postoperative follow-up (FU) and dynamic response to treatment (RTT) assessment of thyroid cancer primarily depends on postoperative neck ultrasound (POU) and thyroglobulin (Tg) determination ( 1 ). This FU strategy is
Search for other papers by Tanvir Rizvi in
Google Scholar
PubMed
Search for other papers by Patrice K. Rehm in
Google Scholar
PubMed
What Is Known about This Topic • Thyrogen® is commonly used for serum thyroglobulin testing, for radioiodine ( 131 I) imaging in those patients unwilling to undergo thyroid hormone withdrawal, in patients unable to mount an adequate thyroid
Search for other papers by Fahim U. Hassan in
Google Scholar
PubMed
Search for other papers by Hosahalli K. Mohan in
Google Scholar
PubMed
a large majority of patients. Follow-up is life-long with thyroid-stimulating hormone (TSH) suppression and thyroglobulin monitoring. Imaging plays a vital role in the detection, diagnosis, accurate staging and optimal management of patients with
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
persistent disease among those with PTC who underwent total thyroidectomy and were younger than 40 years or older than 60 years; however, only the latter group had a short thyroglobulin-doubling time ( 9 ). This finding is consistent with the fact that
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Iris Erlund in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
Search for other papers by Margaret Rayman in
Google Scholar
PubMed
Search for other papers by Monika Buchberger in
Google Scholar
PubMed
Search for other papers by Uwe Siebert in
Google Scholar
PubMed
Search for other papers by Betina H. Thuesen in
Google Scholar
PubMed
Search for other papers by Michael B. Zimmermann in
Google Scholar
PubMed
Search for other papers by Stefan Grünert in
Google Scholar
PubMed
Search for other papers by John H. Lazarus in
Google Scholar
PubMed
building for harmonized IDD prevention and monitoring, including assessment of thyroglobulin (Tg) as an innovative and cost-effective biomarker of iodine status in individuals and populations; 4. Evaluation of Tg in pregnant women as a biomarker for
Search for other papers by Anne-Sophie Bertrand in
Google Scholar
PubMed
Search for other papers by Antoine Iannessi in
Google Scholar
PubMed
Search for other papers by Isabelle Peyrottes in
Google Scholar
PubMed
Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Search for other papers by Antoine Thyss in
Google Scholar
PubMed
Search for other papers by Pierre-Yves Marcy in
Google Scholar
PubMed
histopathology specimen. No lymph node metastases were found. In June 2012, patient was administered radioactive treatment with iodine-131. Whole-body scintigram did not show any uptake foci; as serum thyroglobulin (Tg) level was still detectable (Tg = 10,5 ng